STOCK TITAN

Apogee Enterprises (APOG) director receives 2,454-share stock grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HAYEK JOSEPH B reported acquisition or exercise transactions in this Form 4 filing.

Apogee Enterprises, Inc. reported that director Joseph B. Hayek received a grant of 2,454 shares of Common Stock on 2026-08-05 at a reported price of $0.0000 per share. The award vests over a three-year vesting period, with 1/3 of the shares vesting on each of 8/5/27, 8/5/28 and 8/5/29. Following this award, Hayek directly holds 2,454 shares of Common Stock. The transaction was not indicated as being made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider HAYEK JOSEPH B
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 2,454 $0.00 $0.00
Holdings After Transaction: Common Stock — 2,454 shares (Direct)
Footnotes (1)
  1. F1. The shares will vest over a three-year vesting period with 1/3 of the shares vesting on each 8/5/27, 8/5/28 and 8/5/29.
Shares granted 2,454 shares Common Stock grant reported for Joseph B. Hayek on 2026-08-05
Transaction price per share $0.0000 per share Reported price for the Common Stock award to Joseph B. Hayek
Shares following transaction 2,454 shares Direct Common Stock holdings after the reported grant
Vesting period three-year vesting period Shares vest with 1/3 on each 8/5/27, 8/5/28 and 8/5/29
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
vesting period financial
"The shares will vest over a three-year vesting period"
A vesting period is the set amount of time someone must wait before they fully own granted shares, stock options, or other equity tied to their work or an agreement; ownership increases gradually or in steps during that time. Investors care because vesting determines when insiders or employees can sell shares, which affects future supply of stock, company incentives and executive retention—think of it like unlocking ownership over installments rather than receiving it all at once.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did APOG report for director Joseph B. Hayek?

Apogee Enterprises (APOG) reported that director Joseph B. Hayek received a grant of 2,454 shares of Common Stock. The shares were awarded on 2026-08-05 and will vest in three equal annual installments beginning on 8/5/27 and ending on 8/5/29.

How many Apogee Enterprises (APOG) shares were granted to Joseph B. Hayek and at what price?

Joseph B. Hayek was granted 2,454 shares of Apogee Enterprises Common Stock at a reported price of $0.0000 per share. This reflects a stock-based award rather than a market purchase, with all 2,454 shares subject to the stated vesting schedule over three years.

When will Joseph B. Hayek’s APOG stock grant vest?

The stock grant to Joseph B. Hayek will vest over a three-year vesting period. According to the disclosure, 1/3 of the shares vest on each of 8/5/27, 8/5/28 and 8/5/29, meaning the award becomes fully vested by August 2029.

How many APOG shares does Joseph B. Hayek hold after this grant?

After the reported grant, Joseph B. Hayek directly holds 2,454 shares of Apogee Enterprises Common Stock. The filing lists this as his total direct ownership following the transaction, with all of these 2,454 shares tied to the new, three-year vesting award.

Was the reported APOG Form 4 transaction made under a Rule 10b5-1 trading plan?

The transaction was not indicated as being made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox was not marked as an affirming plan, suggesting this equity grant is standard director compensation rather than a pre-arranged trading plan transaction.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HAYEK JOSEPH B

(Last)(First)(Middle)
4400 WEST 78TH STREET
SUITE 520

(Street)
MINNEAPOLIS MINNESOTA 55435

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/05/2026A2,454(1)A$02,454D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares will vest over a three-year vesting period with 1/3 of the shares vesting on each 8/5/27, 8/5/28 and 8/5/29.
Remarks:
/s/Bryan A. Welp, Attorney-in-Fact for Joseph B. Hayek08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)